National Health Investors (NYSE:NHI) Issues Quarterly Earnings Results

National Health Investors (NYSE:NHI) announced its quarterly earnings results on Thursday. The real estate investment trust reported $1.32 EPS for the quarter, topping the consensus estimate of $1.24 by $0.08, Zacks reports. The business had revenue of $83.36 million for the quarter, compared to analyst estimates of $85.66 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The company’s quarterly revenue was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.03 EPS. National Health Investors updated its FY 2025 guidance to 4.880-4.91 EPS.

National Health Investors Trading Up 2.2%

NYSE NHI traded up $1.66 during trading hours on Friday, hitting $76.97. 423,563 shares of the company’s stock were exchanged, compared to its average volume of 238,050. National Health Investors has a 12-month low of $65.13 and a 12-month high of $82.32. The business’s 50 day moving average is $76.81 and its 200-day moving average is $74.36. The firm has a market capitalization of $3.65 billion, a P/E ratio of 24.59, a price-to-earnings-growth ratio of 3.31 and a beta of 0.74. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. National Health Investors’s payout ratio is currently 117.57%.

Hedge Funds Weigh In On National Health Investors

A number of large investors have recently bought and sold shares of the stock. State Street Corp grew its stake in shares of National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after buying an additional 95,812 shares during the period. Balyasny Asset Management L.P. lifted its stake in shares of National Health Investors by 66.9% in the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after purchasing an additional 246,486 shares in the last quarter. Qube Research & Technologies Ltd grew its holdings in shares of National Health Investors by 86.0% during the 2nd quarter. Qube Research & Technologies Ltd now owns 319,286 shares of the real estate investment trust’s stock worth $22,388,000 after purchasing an additional 147,591 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after buying an additional 21,851 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of National Health Investors by 4.3% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 231,995 shares of the real estate investment trust’s stock valued at $16,267,000 after acquiring an additional 9,488 shares during the period. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of National Health Investors in a research note on Wednesday, October 8th. KeyCorp upgraded shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price for the company in a report on Thursday, July 10th. National Bankshares set a $90.00 target price on shares of National Health Investors in a research report on Wednesday, October 1st. Truist Financial upped their price target on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a report on Friday, August 15th. Finally, Cantor Fitzgerald initiated coverage on shares of National Health Investors in a research note on Wednesday, October 1st. They set an “overweight” rating and a $90.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.